Хайлтын үр дүнгүүд - Sanjeev Kumar Mendiratta

  • 5-н 1 - 5 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4

    CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4 -н Sanjeev Kumar Mendiratta, William Martin, Seokmann Hong, Alina C. Boesteanu, Sebastian Joyce, Luc Van Kaer

    Хэвлэсэн 1997
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection

    H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection -н William Martin, Geoffrey G. Hicks, Sanjeev Kumar Mendiratta, Hitesh I Leva, H. Earl Ruley, Luc Van Kaer

    Хэвлэсэн 1996
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo

    Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo -н Toshihiko Kawamura, Kazuyoshi Takeda, Sanjeev Kumar Mendiratta, Hiroki Kawamura, Luc Van Kaer, Hideo Yagita∥, Toru Abo, Ko Okumura

    Хэвлэсэн 1998
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    A prospective, randomized, double‐blind, multicentre, parallel‐group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; <scp>ZRC</scp>‐3197) and adalimumab (Humira) in patients with rheumatoid arthritis

    A prospective, randomized, double‐blind, multicentre, parallel‐group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; <scp>ZRC</scp>‐3197... -н Rajendrakumar H. Jani, Rajiv Gupta, Girish Bhatia, Gaurav Rathi, Patnala Ashok Kumar, Reena Sharma, Uma Kumar, Liyakat Ali Gauri, Praveen Jadhav, Girishchandra Bartakke, Vikram Haridas, Dinesh Jain, Sanjeev Kumar Mendiratta

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)

    A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG) -н Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, Jatin Patel, Shuchi Joshi, Nitin Sharma, Anurag Parihar, Swapnil Bhoge, Harilal Patel, Pankaj Kalita, Renuka Munshi, Prakash Kurmi, Ruchir Shah, Abhishek Gupta, Hira Lal Bhalla, Harish Bekkalele, RajendraKumar Verma, Dinesh Agarwal, Shrikant Sharma, Avinash Gawande, Gaurav Chhaya

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: